Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-17T23:39:02.421Z Has data issue: false hasContentIssue false
  • English
  • Français

Regarding the Treatment of General Paralysis

Published online by Cambridge University Press:  19 February 2018

G. H. Monrad-Krohn
G. H. Monrad-Krohn*
Affiliation:
Neurological Section of Rikshospitalet, Christiania; Royal Frederick University, Christiania
Get access Rights & Permissions [Opens in a new window]

Extract

When Noguchi found spirochaetes in the brain of general paralytics some years ago it seemed as if we were entering into a new era, not only in the pathological conception of the so-called “parasyphilitic” or “metasyphilitic” affections, but also in their treatment. In this latter respect most of us have hitherto been somewhat disappointed, and it may therefore be advisable to take up the rationale of the treatment for revision.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 66 , Issue 272 , January 1920 , pp. 46 - 48
Copyright
Copyright © Royal College of Psychiatrists, 1920 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

(1) If the spirochæte has a life-cycle (as McDonagh will have it), it would not be surprising to find certain phases of the life-cycle immune to the usual anti-syphilitic remedies.—(2) With regard to the modifications they propose, I shall just mention that after injection of the full dose of 0.9 neosalvarsan arsenic can be found in the blood, and anyway, it is on account of such concentration in the blood after intravenous injections that it acts on syphilitic lesions in other organs. Why should a stronger concentration be needed in the brain?Google Scholar

Submit a response

eLetters

No eLetters have been published for this article.